Literature DB >> 15523308

Impaired coronary blood flow in patients with metabolic syndrome: documented by Thrombolysis in Myocardial Infarction (TIMI) frame count method.

Hasan Turhan1, Ali Riza Erbay, Ayse Saatci Yasar, Asuman Bicer, Hatice Sasmaz, Ertan Yetkin.   

Abstract

BACKGROUND: Endothelium plays an important role in regulating coronary vascular tone. In addition, several of cardiovascular risk factors that are associated metabolic syndrome have been reported to be associated with endothelial dysfunction. In the present study we aimed to evaluate the coronary blood flow in patients with metabolic syndrome by means of the Thrombolysis in Myocardial Infarction (TIMI) frame count.
METHOD: Forty-two patients with metabolic syndrome (group I) and 42 control subjects without metabolic syndrome (group II) were included in the study. All subjects had angiographically proven normal coronary arteries. Diagnosis of metabolic syndrome was based on the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines published in 2001. Coronary flow rates of all subjects were documented by TIMI frame count method.
RESULTS: TIMI frame counts for each of the major epicardial coronary arteries were found to be significantly higher in patients with metabolic syndrome compared with control subjects (corrected TIMI frame count for left anterior descending coronary artery: 35 +/- 7 vs 25 +/- 7, respectively; left circumflex coronary artery: 32 +/- 9 vs 25 +/- 7, respectively; right coronary artery: 31 +/- 9 vs 24 +/- 5, respectively; P < .001 for all). Statistically significant independent relationships were found between TIMI frame count and body mass index (R(2) = 0.480, P = .009), waist circumference (R2 = 0.551, P = .001), and triglyceride level (R2 = 0.434, P = .036).
CONCLUSION: We have shown for the first time that patients with metabolic syndrome and angiographically normal coronary arteries have higher TIMI frame counts for all 3 coronary vessels, indicating impaired coronary blood flow, compared to control subjects without metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15523308     DOI: 10.1016/j.ahj.2004.05.016

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  14 in total

Review 1.  Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years.

Authors:  Vijayalakshmi Kunadian; Caitlin Harrigan; Cafer Zorkun; Alexandra M Palmer; Katherine J Ogando; Leah H Biller; Erin E Lord; Scott P Williams; Michelle E Lew; Lauren N Ciaglo; Jacqueline L Buros; Susan J Marble; William J Gibson; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2008-04-20       Impact factor: 2.300

2.  Predictive value of the corrected TIMI frame count in patients with suspected angina pectoris but no obstructive coronary artery disease at angiography.

Authors:  Lasse Jespersen; Steen Z Abildstrøm; Adam Peña; Peter R Hansen; Eva Prescott
Journal:  Clin Res Cardiol       Date:  2014-01-20       Impact factor: 5.460

3.  Impaired coronary collateral vessel development in patients with proliferative diabetic retinopathy.

Authors:  Turgay Celik; M Eyup Berdan; Atila Iyisoy; Hurkan Kursaklioglu; Hasan Turhan; Selim Kilic; Mustafa Gulec; Sami Ozturk; Ersoy Isik
Journal:  Clin Cardiol       Date:  2005-08       Impact factor: 2.882

4.  Impaired coronary blood flow may be related to elevated homocysteine levels in patients with metabolic syndrome.

Authors:  Yusuf I Alihanoglu; Bekir S Yildiz; Emin E Özcan; Ismail D Kilic; Deniz S Kuru; Ozgur Taskoylu; Halil Tanriverdi; Havane A Kaftan; Harun Evrengul
Journal:  Wien Klin Wochenschr       Date:  2015-09-16       Impact factor: 1.704

5.  Impaired coronary microvascular endothelial function in men with metabolic syndrome.

Authors:  Hiroki Teragawa; Naoya Mitsuba; Kenji Nishioka; Kentaro Ueda; Shingo Kono; Yukihito Higashi; Kazuaki Chayama; Yasuki Kihara
Journal:  World J Cardiol       Date:  2010-07-26

6.  Coronary blood flow is slower in prediabetic and diabetic patients with normal coronary arteries compared with nondiabetic patients.

Authors:  Uğur Arslan; Mustafa Mücahit Balcı; Ibrahim Kocaoğlu
Journal:  Exp Clin Cardiol       Date:  2012

7.  Exercise reveals impairments in left ventricular systolic function in patients with metabolic syndrome.

Authors:  Sara B Fournier; Brian L Reger; David A Donley; Daniel E Bonner; Bradford E Warden; Wissam Gharib; Conard F Failinger; Melissa D Olfert; Jefferson C Frisbee; I Mark Olfert; Paul D Chantler
Journal:  Exp Physiol       Date:  2013-09-13       Impact factor: 2.969

8.  Diverse spectrum of presentation of coronary slow flow phenomenon: a concise review of the literature.

Authors:  Muhammad A Chaudhry; Marcus Smith; Elias B Hanna; Ralph Lazzara
Journal:  Cardiol Res Pract       Date:  2012-05-08       Impact factor: 1.866

9.  The Effect of Metabolic Syndrome on Myocardial Contractile Reserve during Exercise in Non-Diabetic Hypertensive Subjects.

Authors:  Tae Hoon Ha; Hye-Sun Seo; Woo Jin Choo; Jaehuk Choi; Jon Suh; Youn-Haeng Cho; Nae-Hee Lee
Journal:  J Cardiovasc Ultrasound       Date:  2011-12-27

10.  Endothelial function in patients with slow coronary flow and normal coronary angiography.

Authors:  Luis Ulisses Signori; Alexandre Schaan de Quadros; Graciele Sbruzzi; Thiago Dipp; Renato D Lopes; Beatriz D'Agord Schaan
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.